Caricamento...

Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer

The anti-angiogenic agent bevacizumab has been approved for the treatment of non-small cell lung cancer, although the survival benefit associated with this agent is marginal, and toxicities and cost are substantial. A recent screen for selective inhibitors of endothelial cell proliferation identifie...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Aftab, Blake T., Dobromilskaya, Irina, Liu, Jun O., Rudin, Charles M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2011
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3206167/
https://ncbi.nlm.nih.gov/pubmed/21896639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-11-0691
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !